<DOC>
	<DOCNO>NCT01688349</DOCNO>
	<brief_summary>The purpose trial investigate impact cortisol adipose tissue function , distribution morphology . Patient endogenous blood cortisol excess exhibit change adipose tissue , fat gain upper trunk , face neck lead visceral obesity feature metabolic syndrome . The aim study - compare pattern gene expression visceral subcutaneous adipose tissue Cushing patient require adrenalectomy cortisol adenoma treatment ; - compare pattern gene expression two control populations:1/ healthy metabolic subject partial nephrectomy , 2/obese patient similar degree insulin resistance .</brief_summary>
	<brief_title>Pattern Gene Expression Adipose Tissue From Patients With Cushing Syndrome</brief_title>
	<detailed_description>Cushing 's syndrome rare disease result chronic exposure glucocorticoid ( endogenous iatrogenic ) abnormal fat distribution ( lipodystrophy ) . Glucocorticoids regulate function adipose tissue ( AT ) target adipocyte differentiation well anabolic , catabolic secretory pathway adipocyte . However , mechanisms glucocorticoid differentially disrupt development metabolism AT deep superficial deposit remain unknown . Among main effector glucocorticoid signal pathway , 11 beta-hydroxysteroid deshydrogenase ( 11beta-HSD1 ) , regenerate cortisol cortisone , likely key step biological effect glucocorticoid AT . Identifying mechanisms action glucocorticoid different fat depot require comparison fatty deposit derive two type control population : 1/ normal weight individual without inflammatory metabolic disorder ( controls1 ) ; 2/individuals obese match level insulin resistance ( controls2 ) . Hypothesis : Excess glucocorticoid cause abnormal fat distribution via direct effect various deposit AT , lead secondarily insulin resistance . Primary endpoint : To compare gene expression glucocorticoid signal visceral AT ( VAT ) Cushing patient controls1 ( match age sex ) . Secondary endpoint : 1 . For patient Cushing controls1 , compare respective subcutaneous AT ( SCAT ) VAT : - The expression gene involve differentiation inflammation AT , - Morphological aspect : adipocyte size , fibrosis , inflammation , immunohistochemistry . 2 . Same parameter Cushing patient controls2 ( match sex , age + / -5 , HOMA-R + / -1 ) , differentiate specific effect glucocorticoid effect insulin resistance , 3 . To compare parameter SCAT VAT Cushing patient . Methodology experimental design : non-randomized comparative multicenter study constitution biological collection . Patients recruit endocrinology adrenalectomy controls1 urology . They preoperative assessment sample perirenal AT SCAT surgery . Controls2 already include CRC2007-P050318 drawn matching . Number patient need : We assume relative gene expression 11β-HSD1 VAT expose glucocorticoid = 0.81 ± 0.121 . Our recruitment potential Cushing patient 30 patient . With 30 patient per group , able detect difference 11β-HSD1 gene expression VAT Cushing patient least 15 % high compare controls1 .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Cushing Syndrome</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<criteria>Cases : Adults Cushing 's syndrome secondary adrenal adenoma . Controls1 : Adults normal weight : BMI &lt; 25 , partial nephrectomy Controls2 adult common obesity treat bariatric surgery , BMI &gt; 35kg/m2 Diabetes , renal hepatic impairment , pregnancy , menopause , HIV HCV , Cushing 's syndrome due cause cortisol adenoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Glucocorticoids</keyword>
	<keyword>adipose tissue</keyword>
	<keyword>Cushing</keyword>
	<keyword>lipodystrophy</keyword>
	<keyword>11 beta-HSD1</keyword>
</DOC>